Cassidy RN, Tidey JW, Jackson KM, Cioe PA, Murphy SE, Krishnan-Sarin S, Hatsukami D, Colby SM., 2023. The Impact of Reducing Nicotine Content on Adolescent Cigarette Smoking and Nicotine Exposure: Results From a Randomized Controlled Trial. Nicotine Tob Res, 25 (5): 918-927.
doi: https://doi.org/10.1093/ntr/ntac279
PubMed ID: 36482794
Meier E, Rubin N, Dermody SS, Tessier KM, Hecht SS, Murphy S, Jensen J, Donny EC, al'Absi M, Drobes D, Koopmeiners J, Denlinger-Apte R, Tidey JW, Vandrey R, Thorne C, Hatsukami D., 2023. Immediate Switching to Reduced Nicotine Cigarettes in a U.S.-Based Sample: The Impact on Cannabis Use and Related Variables at 20 Weeks. Nicotine Tob Res, 25 (5): 867-874.
doi: https://doi.org/10.1093/ntr/ntac231
PubMed ID: 36198101
Edwards KC, Ozga JE, Reyes-Guzman C, Smith D, Hatsukami D, Hart JL, Jackson A, Goniewicz M, Stanton CA., 2023. Associations between biomarkers of nicotine/tobacco exposure and respiratory symptoms among adults who exclusively smoke cigarettes in the U.S.: Findings from the PATH Study Waves 1-4 (2013-2017). Addict Behav Rep, 17:100487
doi: https://doi.org/10.1016/j.abrep.2023.100487
PubMed ID: 37008740
Denlinger-Apte RL, Cassidy RN, Donny EC, Godin J, Hatsukami DK, Strahley AE, Wiseman KD, Colby SM, Tidey JW., 2023. Qualitative reactions to a low nicotine product standard for cigarettes from adolescents and young adults living in the United States who smoke.. Prev Med Rep, 32: 102163.
doi: https://doi.org/10.1016/j.pmedr.2023.102163
PubMed ID: 36895826
Katz SJ, Petersen A, Liu H, Cohen E, Hatsukami D., 2023. Vaping Flavors and Flavor Representation: A Test of Youth Risk Perceptions, Novelty Perceptions, and Susceptibility. Nicotine Tob Res, 25 (3): 590-595.
doi: https://doi.org/10.1093/ntr/ntac192
PubMed ID: 35931419
Diaz D, Luo X, Hatsukami DK, Donny EC, O'Connor RJ., 2022. Cigarette filter ventilation, smoking topography, and subjective effects: A mediational analysis. Drug and alcohol dependence. Drug Alcohol Depend, 241: 109683.
doi: https://doi.org/10.1016/j.drugalcdep.2022.109683
PubMed ID: 36379202
Paulin, L.M., Halenar, M.J., Edwards, K.C. Hatsukami, D. et al. , 2022. Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013–2019) of the Population Assessment of Tobacco and Health (PATH) Study. Respiratory Research, 23 (273)
doi: https://doi.org/10.1186/s12931-022-02197-1
Mowls Carroll D, Hatsukami D, Denlinger-Apte R., 2022. Prioritize health equity when implementing a nicotine product standard. Nicotine & Tobacco Research, 25 (1): 173-174.
doi: https://doi.org/10.1093/ntr/ntac173
PubMed ID: 35867991
Klemperer EM, Luo X, Jensen J, al'Absi M, Cinciripini PM, Robinson JD, Drobes DJ, McClernon J, Strasser AA, Strayer LG, Vandrey R, Benowitz NL, Donny EC, Hatsukami DK., 2022. Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes. Prev Med, 165 (Pt B): 107175.
doi: https://doi.org/10.1016/j.ypmed.2022.107175
PubMed ID: 35870575
Chen M, Carmella SG, Lindgren BR, Luo X, Ikuemonisan J, Niesen B, Thomson NM, Murphy SE, Hatsukami DK, Hecht SS., 2022. Increased levels of the acrolein metabolite 3-hydroxypropyl mercapturic acid in the urine of e-cigarette users. Chem Res Toxicol, 36 (4): 583-588.
doi: https://doi.org/10.1021/acs.chemrestox.2c00145
PubMed ID: 35858275